Board meeting to approve September 2026 financial results

EBITDA margin compressionResults View source PDF Explain this filing

WINDLAS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-6.2%Reaction day

₹924.60

prior close

₹885.20

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-2.5%-3.7% vs market

Pharmaceuticals peers, median of 173sector-0.8%-5.4% vs sector

On the reaction day the stock moved 3.7 pts less than Nifty Microcap 250 and 5.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.2

10m

+0.1

15m

-0.0

30m

-0.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-6.2-2.5-3.7-0.8-5.4

Next day

-0.9-1.1+0.2-0.7-0.2

-4.8-0.8-4.0-0.5-4.4

-5.4+1.3-6.7+0.4-5.7

-0.7+2.5-3.2+1.4-2.1

+7.9pendingpending+1.3+6.6

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Board will meet on November 5, 2026 to approve the unaudited standalone results for the quarter and half year ended September 30, 2026. The trading window has been closed since October 1 and will reopen 48 hours after the results are declared.

Likely market impact

Results are still pending, so no performance figures are available. The filing only confirms the approval date and trading window status.

By the numbersStandalone · Q2 FY27 vs Q2 FY26

	Q2 FY27	Q2 FY26	Change
Revenue	₹263.9 Cr	₹222.4 Cr	+18.7%
Operating profit	₹19.44 Cr	₹19.94 Cr	−2.5%
Profit after tax	₹18.05 Cr	₹17.80 Cr	+1.4%
EBITDA margin	11.1%	12.8%	−1.7 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.